Azimuth Biologics

About Azimuth Biologics

We're a dedicated team of medical professionals, immunologists, and pioneers driving innovations against flaviviruses with unmatched experience.

Adam Waickman, PhD.

Co-Founder, Chief Executive Officer

Assistant professor at SUNY Upstate Medical University, experienced immunologist, and lead inventor on the technology being developed by Azimuth Biologics, Inc.

Stephen Thomas, MD.

Co-Founder, Chief Medical Officer

Professor of Medicine, Chair of the Department of Microbiology and Immunology, and Director of the Institute for Global Health and Translational Sciences at SUNY Upstate Medical University. 25+ years of experience in developing and licensing infectious disease countermeasures.

Robert A. Gasser, Jr., MD.

Co-Founder, Chief Scientific Officer

Infectious diseases physician with extensive clinical practice experience and more than 25 years of work in developing and obtaining regulatory approval for monoclonal antibodies, diagnostics, and vaccines for infectious diseases. Adjunct Professor of Medicine, Uniformed Services University.

Mark Kristiansen, JD.

Co-Founder, Chief Operating Officer

Technology executive and former general counsel for a multination technology company, leading teams managing operation, M&A, strategic and legal affairs.